Annual Total Expenses
$172.95 M
+$72.06 M+71.41%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual total expenses is currently $172.95 million, with the most recent change of +$72.06 million (+71.41%) on 31 December 2023. During the last 3 years, it has fallen by -$29.83 million (-14.71%). LXRX annual total expenses is now -21.46% below its all-time high of $220.21 million, reached on 31 December 2017.LXRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$65.44 M
+$8.44 M+14.81%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly total expenses is currently $65.44 million, with the most recent change of +$8.44 million (+14.81%) on 30 September 2024. Over the past year, it has increased by +$15.65 million (+31.43%). LXRX quarterly total expenses is now -9.29% below its all-time high of $72.14 million, reached on 30 June 2020.LXRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.4% | +31.4% |
| 3 y3 years | -14.7% | +184.7% |
| 5 y5 years | +3.9% | +59.1% |
LXRX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.7% | +97.9% | at high | +184.7% |
| 5 y | 5 years | -14.7% | +97.9% | -9.3% | +781.5% |
| alltime | all time | -21.5% | +888.3% | -9.3% | +781.5% |
Lexicon Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $65.44 M(+14.8%) |
| June 2024 | - | $57.00 M(+22.7%) |
| Mar 2024 | - | $46.46 M(-2.1%) |
| Dec 2023 | $172.95 M(+71.4%) | $47.44 M(-4.7%) |
| Sept 2023 | - | $49.79 M(+11.8%) |
| June 2023 | - | $44.56 M(+43.0%) |
| Mar 2023 | - | $31.17 M(+2.8%) |
| Dec 2022 | $100.90 M(+15.5%) | $30.31 M(+31.0%) |
| Sept 2022 | - | $23.13 M(-3.8%) |
| June 2022 | - | $24.04 M(+2.7%) |
| Mar 2022 | - | $23.42 M(-7.6%) |
| Dec 2021 | $87.39 M(-56.9%) | $25.34 M(+10.3%) |
| Sept 2021 | - | $22.98 M(+26.3%) |
| June 2021 | - | $18.19 M(-12.8%) |
| Mar 2021 | - | $20.87 M(+181.1%) |
| Dec 2020 | $202.78 M(+33.4%) | $7.42 M(-85.9%) |
| Sept 2020 | - | $52.78 M(-26.8%) |
| June 2020 | - | $72.14 M(+2.4%) |
| Mar 2020 | - | $70.44 M(+25.9%) |
| Dec 2019 | $151.99 M(-8.7%) | $55.94 M(+36.0%) |
| Sept 2019 | - | $41.13 M(+45.7%) |
| June 2019 | - | $28.23 M(+5.8%) |
| Mar 2019 | - | $26.68 M(-9.4%) |
| Dec 2018 | $166.49 M(-24.4%) | $29.44 M(-1.5%) |
| Sept 2018 | - | $29.89 M(-32.2%) |
| June 2018 | - | $44.07 M(-30.1%) |
| Mar 2018 | - | $63.09 M(+6.7%) |
| Dec 2017 | $220.21 M(+6.3%) | $59.13 M(+4.7%) |
| Sept 2017 | - | $56.46 M(+22.9%) |
| June 2017 | - | $45.95 M(-21.7%) |
| Mar 2017 | - | $58.68 M(+45.6%) |
| Dec 2016 | $207.13 M(+74.0%) | $40.30 M(-37.8%) |
| Sept 2016 | - | $64.80 M(+14.4%) |
| June 2016 | - | $56.63 M(+24.7%) |
| Mar 2016 | - | $45.40 M(+23.1%) |
| Dec 2015 | $119.02 M(+9.5%) | $36.89 M(+29.5%) |
| Sept 2015 | - | $28.49 M(+5.2%) |
| June 2015 | - | $27.08 M(+1.9%) |
| Mar 2015 | - | $26.57 M(+10.6%) |
| Dec 2014 | $108.69 M(+1.8%) | $24.02 M(-16.4%) |
| Sept 2014 | - | $28.73 M(+9.1%) |
| June 2014 | - | $26.34 M(-11.0%) |
| Mar 2014 | - | $29.61 M(+25.1%) |
| Dec 2013 | $106.80 M(+7.2%) | $23.68 M(-21.4%) |
| Sept 2013 | - | $30.12 M(+6.2%) |
| June 2013 | - | $28.36 M(+15.1%) |
| Mar 2013 | - | $24.65 M(-1.0%) |
| Dec 2012 | $99.62 M | $24.91 M(+5.6%) |
| Sept 2012 | - | $23.59 M(+0.3%) |
| June 2012 | - | $23.52 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $27.60 M(+2.5%) |
| Dec 2011 | $109.18 M(+11.5%) | $26.92 M(+3.4%) |
| Sept 2011 | - | $26.05 M(-1.6%) |
| June 2011 | - | $26.48 M(-10.9%) |
| Mar 2011 | - | $29.73 M(+41.8%) |
| Dec 2010 | $97.92 M(-2.7%) | $20.97 M(-16.2%) |
| Sept 2010 | - | $25.03 M(-1.1%) |
| June 2010 | - | $25.31 M(-4.9%) |
| Mar 2010 | - | $26.61 M(+14.4%) |
| Dec 2009 | $100.66 M(-21.9%) | $23.26 M(-2.6%) |
| Sept 2009 | - | $23.89 M(-7.3%) |
| June 2009 | - | $25.77 M(-7.1%) |
| Mar 2009 | - | $27.74 M(+1.8%) |
| Dec 2008 | $128.86 M(+3.0%) | $27.24 M(-15.8%) |
| Sept 2008 | - | $32.33 M(-10.1%) |
| June 2008 | - | $35.95 M(+7.9%) |
| Mar 2008 | - | $33.33 M(+3.3%) |
| Dec 2007 | $125.07 M(-2.3%) | $32.27 M(+9.0%) |
| Sept 2007 | - | $29.61 M(-3.2%) |
| June 2007 | - | $30.60 M(-6.1%) |
| Mar 2007 | - | $32.59 M(+6.4%) |
| Dec 2006 | $128.03 M(+14.5%) | $30.64 M(-5.2%) |
| Sept 2006 | - | $32.32 M(-2.4%) |
| June 2006 | - | $33.10 M(+3.5%) |
| Mar 2006 | - | $31.98 M(+13.5%) |
| Dec 2005 | $111.80 M(+2.4%) | $28.17 M(+0.5%) |
| Sept 2005 | - | $28.02 M(-1.4%) |
| June 2005 | - | $28.42 M(+4.5%) |
| Mar 2005 | - | $27.19 M(-1.0%) |
| Dec 2004 | $109.19 M(+3.6%) | $27.47 M(+1.5%) |
| Sept 2004 | - | $27.06 M(-0.6%) |
| June 2004 | - | $27.22 M(-0.8%) |
| Mar 2004 | - | $27.45 M(+5.4%) |
| Dec 2003 | $105.43 M(+7.5%) | $26.04 M(-3.5%) |
| Sept 2003 | - | $26.98 M(+0.8%) |
| June 2003 | - | $26.77 M(+4.4%) |
| Mar 2003 | - | $25.64 M(+3.8%) |
| Dec 2002 | $98.09 M(+32.2%) | $24.70 M(-3.1%) |
| Sept 2002 | - | $25.50 M(+1.8%) |
| June 2002 | - | $25.05 M(+9.7%) |
| Mar 2002 | - | $22.83 M(-0.3%) |
| Dec 2001 | $74.22 M(+48.6%) | $22.90 M(+6.8%) |
| Sept 2001 | - | $21.45 M(+36.3%) |
| June 2001 | - | $15.74 M(+11.4%) |
| Mar 2001 | - | $14.13 M(+2.7%) |
| Dec 2000 | $49.94 M(+185.3%) | $13.76 M(+31.0%) |
| Sept 2000 | - | $10.50 M(+18.1%) |
| June 2000 | - | $8.89 M(-47.0%) |
| Mar 2000 | - | $16.78 M |
| Dec 1999 | $17.50 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual total expenses year-on-year change?
- What is Lexicon Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly total expenses year-on-year change?
What is Lexicon Pharmaceuticals annual total expenses?
The current annual total expenses of LXRX is $172.95 M
What is the all time high annual total expenses for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual total expenses is $220.21 M
What is Lexicon Pharmaceuticals annual total expenses year-on-year change?
Over the past year, LXRX annual total expenses has changed by +$72.06 M (+71.41%)
What is Lexicon Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of LXRX is $65.44 M
What is the all time high quarterly total expenses for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly total expenses is $72.14 M
What is Lexicon Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, LXRX quarterly total expenses has changed by +$15.65 M (+31.43%)